metricas
covid
Buscar en
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Toda la web
Inicio Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) Fibroelastic pseudotumour elastofibroma dorsi detected by 18F-FDG PET/CT and by ...
Journal Information
Vol. 37. Issue 1.
Pages 46-49 (January - February 2018)
Share
Share
Download PDF
More article options
Visits
1
Vol. 37. Issue 1.
Pages 46-49 (January - February 2018)
Clinical note
Fibroelastic pseudotumour elastofibroma dorsi detected by 18F-FDG PET/CT and by posttherapy radioiodine SPECT/CT
Pseudotumor fibroelástico elastofibroma dorsi detectado por 18F-FDG PET/TC y por 131I SPECT/TC posterapia
Visits
1
M. Oportoa,
Corresponding author
magdalena.oporto@ssib.es

Corresponding author.
, F. Cepaa, N. Ortaa, S. Rubía,b, H. Navalóna, C. Peñaa,b
a Servicio de Medicina Nuclear, Hospital Universitario Son Espases, Spain
b Instituto de Investigación Sanitaria de Palma, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (4)
Show moreShow less
Abstract

Radioiodine uptake in the thyroid tissue, metastasis of differentiated thyroid cancer (DTC), and in other tissues, depends on the expression of sodium-iodide symporter (NIS). Vascular permeability, effusions, inflammation, and other mechanisms may also play a role in the accumulation of radioactive iodine. A 63-year-old woman underwent radioiodine therapy, as well as a post-therapy whole-body scan,as she was suspected of having lung metastasis from thyroid carcinoma. The scan not only showed uptake at the lung metastasis but also a faint diffuse bilateral uptake in the posterior thorax. On SPECT/CT this uptake was located in a known ElastofibromaDorsi (ED) previously diagnosed by contrast CT and viewed in a FDG PET/CT. The radioiodine uptake in ED, especially if typical, is not a diagnostic problem in SPECT/CT study, but can be misleading in a study limited to a few planar images, particularly if the uptake occurs asymmetrically, or ED is located in a unsuspected area.

Keywords:
Elastofibroma Dorsi
Radioiodine
Differentiated thyroid cancer
False positive scan
I-131-radioiodine SPECT CT
Resumen

La captación de yodo radioactivo en el tejido tiroideo y en las metástasis del cáncer diferenciado de tiroides (DTC) y otros tejidos depende de la expresión del transportador de sodio-yodo (NIS). La permeabilidad vascular, derrames serosos, procesos inflamatorios y otros mecanismos tambièc)n pueden desempeñar un papel en la acumulación de yodo radioactivo. Una mujer de 63 años fue sometida a terapia con yodo radiactivo y a un estudio de cuerpo completo despuèc)s de la terapia, debido a la sospecha de metástasis pulmonar de carcinoma diferenciado de tiroides. La exploración no solo mostró captación en la metástasis de pulmón, sino tambièc)n una captación difusa leve en la región posterior del tórax en ambos lados; en el SPECT/TC esta captación se localiza en un ED ya conocido, previamente diagnosticado mediante TC con contraste y visto tambièc)n en un FDG-PET/CT. La captación de radioyodo en el ED, sobre todo si es típico, no plantea un problema de diagnóstico en el estudio de SPECT/CT, pero puede inducir a error en un estudio limitado a unas pocas imágenes planares, especialmente si la captación se produce de forma asimèc)trica, o el ED se encuentra en una localización insospechada.

Palabras clave:
Elastofibroma Dorsi
Radioyodo
Carcinoma diferenciado de tiroides
Falso positivo scan
I-131 SPECT/CT

Article

These are the options to access the full texts of the publication Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos